Diabetic foot is one of the most challenging and complex conditions in modern medicine. Effective healing of a diabetic wound requires the precise synchronization of more than 30 physiological and clinical processes - much like a philharmonic orchestra working in perfect harmony.
In response to the significant clinical challenges and the lack of comprehensive treatment solutions, TriO was founded. The company has developed a novel, integrated device designed to address the multiple therapeutic actions required for diabetic foot treatment simultaneously. The device is designed for ease of use and can be operated in hospitals or clinics at the optimal time to support the healing process. The next generation of the device is intended to support operation by family members.
When implemented as part of a treatment protocol for diabetic foot ulcer (DFU) patients, the solution has the potential to significantly improve patient outcomes, reduce the risk of amputation, and support quality of life for people living with diabetes worldwide. The next generation of the device is designed to incorporate built-in AI-based control to further enhance treatment precision and usability.
Our Vision
To fundamentally change medical care and significantly reduce physical and emotional suffering for DFU patients worldwide.
Our Mission
To enable DFU's patients to be treated at home and in clinics with an innovative, effective and affordable medical solution that will improve their health at the most critical stages of healing.
The Key Advantages that Open the Door
to a Worldwide Change
From a ticking time bomb that robs DFU patients of their will to live, to a solution available in every home and local clinic.
Addressing a major medical challenge, our solution
is a breakthrough that offers a paradigm shift in the treatment
of Diabetic Foot Ulcers (DFU).
​
​
Potentially saving
billions of dollars for
global healthcare systems
by reducing hospitalization
costs and associated
medical procedures
related to DFU
User-friendly and affordable, the device is intended for use in clinical settings to support treatment. The next generation is intended for home use, enabling intervention at earlier stages of wound development.
FITT Treats DFU using 3 distinct methods for improved outcomes and treatment cost savings:
Compression therapy - evacuates the edema from the ulcer
Negative Pressure - increases blood flow to the ulcer
Disinfection with Ozone
Prevents unnecessary amputations and the psychological trauma, significantly improving the quality and life expectancy of patients.
​
​
A comprehensive solution, with the next generation of the device intended to include digital applications, AI-based machine learning, and a monitoring application to support the implementation of an optimal clinical regimen and enable protocol adjustments based on collected data.
FITT gives Diabetes patients and their caregivers control over their treatment, reducing both the immense physical and psychological trauma caused by diabetic ulcers.
Our Story
"We love people more for the good we have done them than for the good they have done us."
Leo Tolstoy
The three founders of the project, leading experts in their field, made it their mission driven by a desire to act. A combination of professional curiosity, personal experience with the phenomenon, and a desire to bring something good into the world brought together the key players in this important medical project.
Join Us in Revolutionizing
DFU Treatment Worldwide
The Global Diabetes Epidemic:
-
Over 537 million people currently live with diabetes worldwide.
-
This number is expected to reach 700 million by 2045.
-
25% of people with diabetes will develop DFU, with a 5-year mortality rate of 42%.
-
More than half of DFU patients will develop an infection, leading to 17% undergoing amputation as a treatment.
-
Fear of amputation is greater than fear of death for most diabetic foot patients.
-
The global cost of diabetes in 2015 was estimated at $1.3 trillion.
-
Nearly one-third of direct diabetes costs are attributed to DFU treatment.
